Technavio Expects Global Hematology Analyzers Market to Exceed USD 2.6 Billion by 2020

LONDON--()--According to the latest market research study released by Technavio, the global hematology analyzers market is expected to exceed USD 2.6 billion by 2020, growing at a CAGR of almost 5% during the forecast period.

This research report titled ‘Global Hematology Analyzers Market 2016-2020’, provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes an up to date analysis and forecast for various market segments and all geographical regions.

Request sample report: http://goo.gl/sozI0G

The report segments the global hematology analyzers market by product type and can be divided into three broad categories:

  • Large capital equipment hematology analyzers
  • Bench-top hematology analyzers
  • POC hematology analyzers

Large capital equipment hematology analyzers

The global large capital equipment hematology analyzers market is likely to reach USD 1.3 billion by 2020, growing at a CAGR of over 4.5%.

Large capital equipment hematology analyzers are large automated integrated systems that combine all forms of sample processing, analysis, and presentation of results. These systems are controlled by laboratory information management system (LIMS) to generate high throughput analysis of sample. They also help in pre- and post-analytical sample handling and management of reagent supply with limited user interference.

These systems help laboratories generate results in a faster turnaround time, thereby improving the efficiency and labor utilization. Examples of such systems include SysmexXN-9000 Automated Hematology Systems by Sysmex, UniCel DxH Connected Workcell Solutions by Beckman Coulter, and CELL-DYN Sapphire by Abbott Diagnostics. These systems are employed by central laboratories engaged in the analysis of large/ultra large volume of samples.

Bench-top hematology analyzers

The global bench-top hematology analyzers market is projected to exceed USD 1 billion by 2020, growing at a CAGR of around 5%.

The working mechanism of a bench-top hematology analyzer is similar to capital equipment. However, these analyzers are smaller in size compared to capital equipment and can analyze smaller quantities of blood samples in one cycle run. These devices are employed in small and medium-sized laboratories. They are also employed in physician office laboratories (POLs).

According to Barath Palada, lead analyst at Technavio for orthopedics and general medical devices research, “The global bench-top hematology analyzers market is expected to grow at a steady pace during the forecast period driven by the rise in the number of private clinical laboratories supported by an increase in investment, especially from emerging economies.”

POC hematology analyzers

The global POC hematology analyzers market is likely to exceed USD 349 million by 2020, growing at a CAGR of over 6%.

POC hematology testing is carried out near the site of patient care and with a motive to improve economic and medical outcomes by promoting faster therapeutic turnaround time and rapid response. The POC hematology testing fosters an opportunity for physicians to provide immediate feedback to patients and thereby administer efficient treatment.

Hematology tests at POC include hematocrit, hemoglobin, platelet function, and WBC tests. Further, the multiplexed POC hematology testing enhances clinical care delivery and proves useful in disaster and emergency settings, urgent and primary care settings, and home care settings.

“The global POC hematology analyzers market is expected to grow at a rapid rate during the forecast period driven by the demand for hematology testing in developing economies and healthcare centers with limited logistics support and budgetary constraints for procurement of benchtop analyzers,” says Barath.

Technavio healthcare and life sciences research analysts highlight the following four vendors as the top contributors to the global hematology analyzers market:

  • Abbott Diagnostics
  • Beckman Coulter
  • HORIBA
  • Sysmex

Browse Related Reports:

Purchase these three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio’s reports allows you to download any three reports per month for the price of one. Contact enquiry@technavio.com with your requirements and a link to our subscription platform.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

According to the latest market research study released by Technavio, the global hematology analyzers market is expected to exceed USD 2.6 billion by 2020, growing at a CAGR of almost 5%.

$Cashtags

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com